| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.9 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | 0.016 | 0.9 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |